2006 Annual Meeting | New Perspectives on ALS Treatment
06:45 AM - 07:15 AM |
Treating Symptoms of ALS
Robert G. Miller, MD |
|
06:45 AM - 08:30 AM |
Breakfast
|
|
07:15 AM - 07:45 AM |
End-of-Life Issues: ALS
Wendy Johnston, MD, FRCP(C), FAAN |
|
07:45 AM - 08:15 AM |
Clinical Trials
Hiroshi Mitsumoto, MD, FAAN |
|
08:15 AM - 08:30 AM |
Questions and Answers
|
Robert G. Miller, MD | The institution of Dr. Miller has received research support from Nurown. |
Hiroshi Mitsumoto, MD, FAAN | Dr. Mitsumoto has nothing to disclose. |
Wendy Johnston, MD, FRCP(C), FAAN | Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Inc.. Dr. Johnston has a non-compensated relationship as a Board Member with ALS Canada that is relevant to AAN interests or activities. Dr. Johnston has a non-compensated relationship as a Chair with Canadian ALS Clinical Research Group that is relevant to AAN interests or activities. |